Please wait while the formulary information is being retrieved.
MENVEO MENCYW-135 COMPONENT (MENINGOCOCCAL C,Y,W-135,DIP-CONJ VACCINE COMPONENT 2 OF 2/PF)
- Meningococcal vaccination
(PF) 5 mcg x 3/0.5 mL (final) IM solution
- Dosage information is not available
- None
Contraindicated
- fingolimod
- Gilenya
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- Guillain-barre syndrome
- High fever >101 degrees fahrenheit
MENVEO MENCYW-135 COMPONENT (MENINGOCOCCAL C,Y,W-135,DIP-CONJ VACCINE COMPONENT 2 OF 2/PF)
- Meningococcal vaccination
- None
- Anorexia
- Arthralgias
- Diarrhea
- Drowsy
- Fatigue
- Headache disorder
- Induration of skin
- Injection site sequelae
- Irritability
- Malaise
- Myalgias
- Nausea
More Frequent
Severe
Less Severe
- None
- Chills
- Fever
- Skin rash
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Accidental fall
- Anaphylaxis
- Bell's palsy
- Exfoliative dermatitis
- Guillain-barre syndrome
- Syncope
Less Severe
- Blepharoptosis
- Bone pain
- Cellulitis
- Dizziness
- Earache
- Erythema
- Extensive limb swelling after injection
- Facial palsy
- Hearing loss
- Pain in oropharynx
- Pruritus of skin
- Seizure disorder
- Vertigo
Contraindicated
None
Severe Precaution
Mening. Oligo Vacc (A,C,Y, W-135)
Not recommended age < 2 months.
- 1 Day – 59 Days
- Not recommended age < 2 months.
Management or Monitoring Precaution
None
Meningococcal Vaccine A,c,y And W 135
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Meningococcal Vaccine A,c,y And W-135
Insufficient data available.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Meningococcal vaccination | |
| Z20.811 | Contact with and (suspected) exposure to meningococcus |
| Z23 | Encounter for immunization |
| 0-9 | A-Z |
|---|---|
| Z20.811 | Contact with and (suspected) exposure to meningococcus |
| Z23 | Encounter for immunization |
Formulary Reference Tool